Osteopontin splice variants are differential predictors of breast cancer treatment responses

BACKGROUND: Osteopontin is a marker for breast cancer progression, which in previous studies has also been associated with resistance to certain anti-cancer therapies. It is not known which splice variants may mediate treatment resistance. METHODS: Here we analyze the association of osteopontin vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Zduniak, Krzysztof, Agrawal, Anil, Agrawal, Siddarth, Hossain, Md Monir, Ziolkowski, Piotr, Weber, Georg F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940753/
https://www.ncbi.nlm.nih.gov/pubmed/27400751
http://dx.doi.org/10.1186/s12885-016-2484-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940753/
https://www.ncbi.nlm.nih.gov/pubmed/27400751
http://dx.doi.org/10.1186/s12885-016-2484-x

Ejemplares similares